Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: A retrospective cohort study

Junya Kanda, Masakatsu Hishizawa, Atae Utsunomiya, Shuichi Taniguchi, Tetsuya Eto, Yukiyoshi Moriuchi, Ryuji Tanosaki, Fumio Kawano, Yasushi Miyazaki, Masato Masuda, Koji Nagafuji, Masamichi Hara, Minoko Takanashi, Shunro Kai, Yoshiko Atsuta, Ritsuro Suzuki, Takakazu Kawase, Keitaro Matsuo, Tokiko Nagamura-Inoue, Shunichi KatoHisashi Sakamaki, Yasuo Morishima, Jun Okamura, Tatsuo Ichinohe, Takashi Uchiyama

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for adult T-cell leukemia (ATL), raising the question about the role of graft-versusleukemia effect against ATL. In this study, we retrospectively analyzed the effects of acute and chronic graft-versus-host disease (GVHD) on overall survival, disease-associated mortality, and treatmentrelated mortality among 294 ATL patients who received allogeneic HCT and survived at least 30 days posttransplant with sustained engraftment. Multivariate analyses treating the occurrence of GVHD as a time-varying covariate demonstrated that the development of grade 1-2 acute GVHD was significantly associated with higher overall survival (hazard ratio [HR] for death, 0.65; P = .018) compared with the absence of acute GVHD. Occurrence of either grade 1-2 or grade 3-4 acute GVHD was associated with lower disease-associated mortality compared with the absence of acute GVHD, whereas grade 3-4 acute GVHD was associated with a higher risk for treatment-related mortality (HR, 3.50; P < .001). The development of extensive chronic GVHD was associated with higher treatment-related mortality (HR, 2.75; P = .006) compared with the absence of chronic GVHD. Collectively, these results indicate that the development of mild-to-moderate acute GVHD confers a lower risk of disease progression and a beneficial influence on survival of allografted patients with ATL.

Original languageEnglish
Pages (from-to)2141-2148
Number of pages8
JournalBlood
Volume119
Issue number9
DOIs
Publication statusPublished - 2012 Mar 1
Externally publishedYes

Fingerprint

Adult T Cell Leukemia Lymphoma
T-cells
Cell Transplantation
Graft vs Host Disease
Grafts
Cohort Studies
Retrospective Studies
Mortality
Hazards
Survival
Disease Progression
Therapeutics
Multivariate Analysis
Transplants

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Medicine(all)
  • Hematology
  • Cell Biology

Cite this

Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia : A retrospective cohort study. / Kanda, Junya; Hishizawa, Masakatsu; Utsunomiya, Atae; Taniguchi, Shuichi; Eto, Tetsuya; Moriuchi, Yukiyoshi; Tanosaki, Ryuji; Kawano, Fumio; Miyazaki, Yasushi; Masuda, Masato; Nagafuji, Koji; Hara, Masamichi; Takanashi, Minoko; Kai, Shunro; Atsuta, Yoshiko; Suzuki, Ritsuro; Kawase, Takakazu; Matsuo, Keitaro; Nagamura-Inoue, Tokiko; Kato, Shunichi; Sakamaki, Hisashi; Morishima, Yasuo; Okamura, Jun; Ichinohe, Tatsuo; Uchiyama, Takashi.

In: Blood, Vol. 119, No. 9, 01.03.2012, p. 2141-2148.

Research output: Contribution to journalArticle

Kanda, J, Hishizawa, M, Utsunomiya, A, Taniguchi, S, Eto, T, Moriuchi, Y, Tanosaki, R, Kawano, F, Miyazaki, Y, Masuda, M, Nagafuji, K, Hara, M, Takanashi, M, Kai, S, Atsuta, Y, Suzuki, R, Kawase, T, Matsuo, K, Nagamura-Inoue, T, Kato, S, Sakamaki, H, Morishima, Y, Okamura, J, Ichinohe, T & Uchiyama, T 2012, 'Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: A retrospective cohort study', Blood, vol. 119, no. 9, pp. 2141-2148. https://doi.org/10.1182/blood-2011-07-368233
Kanda, Junya ; Hishizawa, Masakatsu ; Utsunomiya, Atae ; Taniguchi, Shuichi ; Eto, Tetsuya ; Moriuchi, Yukiyoshi ; Tanosaki, Ryuji ; Kawano, Fumio ; Miyazaki, Yasushi ; Masuda, Masato ; Nagafuji, Koji ; Hara, Masamichi ; Takanashi, Minoko ; Kai, Shunro ; Atsuta, Yoshiko ; Suzuki, Ritsuro ; Kawase, Takakazu ; Matsuo, Keitaro ; Nagamura-Inoue, Tokiko ; Kato, Shunichi ; Sakamaki, Hisashi ; Morishima, Yasuo ; Okamura, Jun ; Ichinohe, Tatsuo ; Uchiyama, Takashi. / Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia : A retrospective cohort study. In: Blood. 2012 ; Vol. 119, No. 9. pp. 2141-2148.
@article{57e7d7e694bd47ab8f56641a5c92bf8b,
title = "Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: A retrospective cohort study",
abstract = "Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for adult T-cell leukemia (ATL), raising the question about the role of graft-versusleukemia effect against ATL. In this study, we retrospectively analyzed the effects of acute and chronic graft-versus-host disease (GVHD) on overall survival, disease-associated mortality, and treatmentrelated mortality among 294 ATL patients who received allogeneic HCT and survived at least 30 days posttransplant with sustained engraftment. Multivariate analyses treating the occurrence of GVHD as a time-varying covariate demonstrated that the development of grade 1-2 acute GVHD was significantly associated with higher overall survival (hazard ratio [HR] for death, 0.65; P = .018) compared with the absence of acute GVHD. Occurrence of either grade 1-2 or grade 3-4 acute GVHD was associated with lower disease-associated mortality compared with the absence of acute GVHD, whereas grade 3-4 acute GVHD was associated with a higher risk for treatment-related mortality (HR, 3.50; P < .001). The development of extensive chronic GVHD was associated with higher treatment-related mortality (HR, 2.75; P = .006) compared with the absence of chronic GVHD. Collectively, these results indicate that the development of mild-to-moderate acute GVHD confers a lower risk of disease progression and a beneficial influence on survival of allografted patients with ATL.",
author = "Junya Kanda and Masakatsu Hishizawa and Atae Utsunomiya and Shuichi Taniguchi and Tetsuya Eto and Yukiyoshi Moriuchi and Ryuji Tanosaki and Fumio Kawano and Yasushi Miyazaki and Masato Masuda and Koji Nagafuji and Masamichi Hara and Minoko Takanashi and Shunro Kai and Yoshiko Atsuta and Ritsuro Suzuki and Takakazu Kawase and Keitaro Matsuo and Tokiko Nagamura-Inoue and Shunichi Kato and Hisashi Sakamaki and Yasuo Morishima and Jun Okamura and Tatsuo Ichinohe and Takashi Uchiyama",
year = "2012",
month = "3",
day = "1",
doi = "10.1182/blood-2011-07-368233",
language = "English",
volume = "119",
pages = "2141--2148",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia

T2 - A retrospective cohort study

AU - Kanda, Junya

AU - Hishizawa, Masakatsu

AU - Utsunomiya, Atae

AU - Taniguchi, Shuichi

AU - Eto, Tetsuya

AU - Moriuchi, Yukiyoshi

AU - Tanosaki, Ryuji

AU - Kawano, Fumio

AU - Miyazaki, Yasushi

AU - Masuda, Masato

AU - Nagafuji, Koji

AU - Hara, Masamichi

AU - Takanashi, Minoko

AU - Kai, Shunro

AU - Atsuta, Yoshiko

AU - Suzuki, Ritsuro

AU - Kawase, Takakazu

AU - Matsuo, Keitaro

AU - Nagamura-Inoue, Tokiko

AU - Kato, Shunichi

AU - Sakamaki, Hisashi

AU - Morishima, Yasuo

AU - Okamura, Jun

AU - Ichinohe, Tatsuo

AU - Uchiyama, Takashi

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for adult T-cell leukemia (ATL), raising the question about the role of graft-versusleukemia effect against ATL. In this study, we retrospectively analyzed the effects of acute and chronic graft-versus-host disease (GVHD) on overall survival, disease-associated mortality, and treatmentrelated mortality among 294 ATL patients who received allogeneic HCT and survived at least 30 days posttransplant with sustained engraftment. Multivariate analyses treating the occurrence of GVHD as a time-varying covariate demonstrated that the development of grade 1-2 acute GVHD was significantly associated with higher overall survival (hazard ratio [HR] for death, 0.65; P = .018) compared with the absence of acute GVHD. Occurrence of either grade 1-2 or grade 3-4 acute GVHD was associated with lower disease-associated mortality compared with the absence of acute GVHD, whereas grade 3-4 acute GVHD was associated with a higher risk for treatment-related mortality (HR, 3.50; P < .001). The development of extensive chronic GVHD was associated with higher treatment-related mortality (HR, 2.75; P = .006) compared with the absence of chronic GVHD. Collectively, these results indicate that the development of mild-to-moderate acute GVHD confers a lower risk of disease progression and a beneficial influence on survival of allografted patients with ATL.

AB - Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for adult T-cell leukemia (ATL), raising the question about the role of graft-versusleukemia effect against ATL. In this study, we retrospectively analyzed the effects of acute and chronic graft-versus-host disease (GVHD) on overall survival, disease-associated mortality, and treatmentrelated mortality among 294 ATL patients who received allogeneic HCT and survived at least 30 days posttransplant with sustained engraftment. Multivariate analyses treating the occurrence of GVHD as a time-varying covariate demonstrated that the development of grade 1-2 acute GVHD was significantly associated with higher overall survival (hazard ratio [HR] for death, 0.65; P = .018) compared with the absence of acute GVHD. Occurrence of either grade 1-2 or grade 3-4 acute GVHD was associated with lower disease-associated mortality compared with the absence of acute GVHD, whereas grade 3-4 acute GVHD was associated with a higher risk for treatment-related mortality (HR, 3.50; P < .001). The development of extensive chronic GVHD was associated with higher treatment-related mortality (HR, 2.75; P = .006) compared with the absence of chronic GVHD. Collectively, these results indicate that the development of mild-to-moderate acute GVHD confers a lower risk of disease progression and a beneficial influence on survival of allografted patients with ATL.

UR - http://www.scopus.com/inward/record.url?scp=84857779288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857779288&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-07-368233

DO - 10.1182/blood-2011-07-368233

M3 - Article

C2 - 22234682

AN - SCOPUS:84857779288

VL - 119

SP - 2141

EP - 2148

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -